Skip to main content
. 2020 Jan 15;9(2):e014376. doi: 10.1161/JAHA.119.014376

Figure 2.

Figure 2

Incidence rate of stroke/transient ischemic attack (TIA) during initial vitamin K antagonist (VKA) treatment by time since atrial fibrillation (AF) diagnosis. PY indicates person‐years; Incidence rate (IR) of stroke/TIA during VKA treatment were calculated per month since AF diagnosis. IR function by time since AF was fitted using quadratic splines and weighting for variances of the estimated IRs.